Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2021-11-02 00:00:00 ET · period of report 2021-11-01 · accession 0000899243-21-042437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-02 | 2021-11-01+ | KYMR | Gollob Jared | Chief Medical Off | S - Sale+OE | $62.16 | -57.5K | 44.6K | -56% | -$3.57M |
| DM | 2021-11-02 | 2021-11-01+ | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $1.69 | +39.6K | 62.5K | +173% | +$67.0K |
| DM | 2021-11-02 | 2021-11-01+ | KYMR | Gollob Jared | Chief Medical Off | M - OptEx | $0.00 | -39.6K | 40.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | S | D | 7,387 | $60.40 | 59,767 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2021-11-02 | S | D | 1,202 | $64.34 | 24,657 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.13 to $64.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-11-01 | S | D | 15,911 | $62.34 | 28,722 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.03 to $63.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2021-11-01 | S | D | 4,065 | $63.17 | 24,657 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.03 to $63.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2021-11-02 | M | A | 14,996 | $2.08 | 39,653 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-02 | S | D | 8,514 | $62.89 | 31,139 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.13 to $63.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Common | Common Stock | 2021-11-02 | S | D | 5,280 | $63.50 | 25,859 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.13 to $64.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Common | Common Stock | 2021-11-01 | M | A | 4,607 | $2.08 | 67,154 | D | — | — | |
| 9 | Common | Common Stock | 2021-11-01 | M | A | 20,000 | $1.31 | 62,547 | D | — | — | |
| 10 | Common | Common Stock | 2021-11-01 | S | D | 15,134 | $61.50 | 44,633 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.01 to $62.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 11 | Derivative | Stock Option (Right to Buy) | 2021-11-02 | M | D | 14,996 | $0.00 | 118,812 | D | $2.08 · — to 2029-05-22 | 14,996 Common Stock | (F10) The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date. |
| 12 | Derivative | Stock Option (Right to Buy) | 2021-11-01 | M | D | 4,607 | $0.00 | 133,808 | D | $2.08 · — to 2029-05-22 | 4,607 Common Stock | (F10) The shares underlying this stock option shall vest in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date. |
| 13 | Derivative | Stock Option (Right to Buy) | 2021-11-01 | M | D | 20,000 | $0.00 | 40,007 | D | $1.31 · — to 2028-10-31 | 20,000 Common Stock | (F9) Twenty-five percent (25%) of the shares underlying this stock option vested on September 12, 2019 and the remaining shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. |